Dr Dicky Abraham, Executive Director, Project Leadership Group, Global Vaccine and Biologics Commercialization, Merck

Anup Akkihal, Chief Executive, Logistimo

Dr Carl Alving, Former Chief of Adjuvant and Antigen Research & Emeritus Senior Scientist, Walter Reed Army Institute Of Research

Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer

Marty Anderson, Executive Director, Clinical Development - GenMed, Syneos Health

Marty Anderson at World Vaccine Congress Washington 2018

Dr David E. Anderson, CSO, VBI Vaccines

Dr Philip Arlen, President and Chief Executive Officer, Precision Biologics Inc

Dr Bo Arve, Executive Director, Pfizer

Dr Bo Arve at World Vaccine Congress Washington 2018

Prof Fikri Avci, Academy, UGA Center for Molecular Medicine

Dr Victor Ayala, Staff Scientist, ABL, Inc

Dr Victor Ayala at World Vaccine Congress Washington 2018

Dr Allan B Dietz, Director, Immune, Progenitor, and Cell Therapeutics (IMPACT), Division of Transfusion Medicine, Mayo Clinic and Foundation

Dr Wilfried Bakker, Program Manager Viral Vaccines, Intravacc

Ms Emily Bancroft, President, VillageReach

Dr Eliav Barr, Senior Vice President, Infectious Diseases and Vaccines Clinical Development, Merck Research Laboratories

John Barry, Chief Operating Officer, Pharm-Olam

Dr Samik Basu, Director, Adaptimmune Llc

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories

Dr Wolfgang Bender, Chief Medical Officer, Valneva

Jason Berg, Director, Project Management, PPD

Jason Berg at World Vaccine Congress Washington 2018

Franck Berthe, Senior Livestock Specialist, The World Bank

Dr Jay A. Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH

Dr Nina Bhardwaj, Director of Immunotherapy Professor of Medicine, Division of Hematology & Oncology, Tisch Cancer Institute

Dr Todd Black, Executive Director, Infectious Diseases, Merck Research Laboratory

Dr Steven Black, Professor of Pediatrics, Center for Global Health, University of Cincinnati Children’s Hospital in Ohio

Dr David Bloom, Professor of Economics and Demography, Harvard T.H. Chan School of Public Health

Dr Bahram Bob Valamehr, Vice President of Cancer Immunotherapy, Fate Therapeutics

Dr Karin Bok, Senior Vaccine Science Advisor, US Department of Health and Human Services

Dr Ezio Bonvini, CSO, MacroGenics, Inc.

Dr Adrian Bot, Vice President of Translational Medicine, Kite Pharma Inc

Dr Maria Elena Bottazzi, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine

Dr Karen Broder, Medical Officer, US Centers for Disease Control and Prevention

Jennifer Brogdon, Director of Exploratory Immuno Oncology, N.I.B.R.

Matthew Burt, Vaccine Supply Chain Director,, Pfizer

Lynlee Burton, Director of Project Delivery - Vaccines, PRA Health Sciences

Dr Andrea Carfi, Senior Director, Antigen Design and Project Leader, Valera LLC

Dr Andrea Carfi at World Vaccine Congress Washington 2018

Mark P Carthy, Chief Executive Officer, Orion Healthcare Equity Partners

Ana Flavia Carvalho, Director, Sabin Vaccine Institute

Dr Corey Casper, Chief Scientific Officer, Infectious Disease Research Institute

Dr Jean-Charles Cavitte, Research Policy Officer, European Commission

Dr Sumana Chandramouli, Laboratory Head, Preclinical R&D, GSK Vaccines

Dr Sumana Chandramouli at World Vaccine Congress Washington 2018

Dr Pierre Charneau, Head of TheraVectys-Institut Pasteur Joint-Lab, TheraVectys-Institut Pasteur Joint-Lab

Dr Grace Chen, Deputy Chief of the Clinical Trials Program in the VRC, National Institutes of Health

Dr KC Cheng, Senior Director - Analytical and Formulation Development, NIAID, NIH

James Cheyne, Independent Supply Chain Consultant Co-Founder of WHO's Cold Chain Unit, Health Service Logistics

Dr Roman Chicz, Associate Vice President and Global Head Of External Research and Development, Sanofi Pasteur

Mohit Chopra, Senior Manager of USOTC Supply Chain Strategic Improvement, Johnson & Johnson

Dr Michael Ciesielski, Assistant Professor of Neurosurgery & Oncology, Roswell Park Cancer Institute

Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics

Dr Mark Cornfeld, VP, Immuno-Oncology Drug Development, Incyte

Dr Andrew Cox, Senior Research Officer, National Research Council

Dr Andrew Cox at World Vaccine Congress Washington 2018

Ms Rebecca Coyle, Executive Director, American Immunization Registry Association

Dr Alan Cross, Professor of Medicine, University of Maryland School of Medicine

Dr James Crowe, Director of Vanderbilt Vaccine Center, Vanderbilt Vaccine Center

Dr Ildiko Csiki, Vice President - Clinical Development, Inovio Pharmaceuticals

Dr James Cummings, President, ICON Government & Public Health Solutions

Dr Margie Danchin, Paediatrcian and Senior Research Fellow, Murdoch Children's Research Institute, Royal Children's Hospital

Giuseppe Del Giudice, Translational Science Leader, GSK

Dr Arnaud Didierlaurent, Head Adjuvant Platform, GSK Vaccines

Dr Arnaud Didierlaurent at World Vaccine Congress Washington 2018

Dr Rakesh Dixit, Vice President R&D, Global Head, Biologics Safety Assessment, MedImmune Inc

Dr Philip Dormitzer, Vice President and CSO, Viral Vaccines, Pfizer

Matthew Duchars, VP, Product Development, Emergent BioSolutions

Dr Cynthia Dukes, Vice President - Global Project Management, ICON plc

Dr Peter Dull, Deputy Director, Integrated Clinical Vaccine Development, The Bill & Melinda Gates Foundation

Dr Ruth Faden, Founder, Johns Hopkins Berman Institute of Bioethics

Dr Ruth Faden at World Vaccine Congress Washington 2018

Heinz Feldmann, Chief, Laboratory of Virology Chief, Disease Modeling and Transmission Section, NIH

Dr Benjamin Fiebiger, Senior Scientist, Lead Immunologist, Siolta Therapeutics

Dr Veronica Gambillara Fonck, Co-Founder & Chief Executive Officer, LimmaTech Biologics AG

Dr Cyril G Gay, Senior National Program Leader, A.R.S. National Programs

Parrish Galliher, Chief Technology Officer, GE Healthcare LifeScience

Dr Nathalie Garcon, CEO/CSO, BIOASTER

Professor Thomas Geisbert, Professor Microbiology and Immunology, University of Texas Medical Branch

Dr Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute

Dr Don Gerson, CEO, Pnuvax Inc

Dr Brad Gessner, VP for Scientific Affairs at AMP, Faculty at U. Maryland/Centers for Vaccine Development & VP and Director, Global Pneumococcal, Pfizer

Dr Ahmad Ghoniem, Manager of Sales and Business Development, tesa Labtec

Dr Basav Ghosh, Sr. Director, Pfizer

Jeremy Gillespie, Global sales Director, Kerry

Dr Ann Ginsberg, Chief Medical Officer, AERAS

Geoffrey Glauser, Senior Consultant Supply Chain, HHS - ASPR - BARDA

Dr Gregory Glenn, President, Research and Development, Novavax

Dr Barney Graham, Deputy Director of Vaccine Research Center, National Institute of Allergy and Infectious Diseases

Dr Duane J Gubler, Emeritus Professor, Programme in Emerging Infectious Diseases, Duke-NUS Graduate Medical School

Dr Farshad Guirakhoo, CSO, GeoVax, Inc.

Dr Nir Hacohen, Director of the Center for Cancer Immunology and Co-Director of the Center for Cell Circuits, Broad Institute and Massachusetts General Hospital

Dr Lee Hall, Chief of Parasitology and International Programs Branch, PIPB DMID NIAID NIH

Dr Neal Halsey, Professor of International Health, Director of the Institute for Vaccine Safety, Johns Hopkins

Dr Scott Halstead, Adjunct Professor, Department of Preventive Medicine and Biometrics, Immune Analytics LLC

Dr Ahd Hamidi, Project Director, Batavia Biosciences

Dr Talitha Hampton, Lead, Supply Chain Packaging and Product Security, AstraZeneca LP

Dr Talitha Hampton at World Vaccine Congress Washington 2018

Paddy Hanlon, V.P., Marken

Charles Heffernan, Former Supply Chain Transformation and Technology Innovation Lead, GSK & Member, BioPhorum Operations Group

Ana Maria Henao Restrepo, Implementation Research and Economic Analysis, Initiative for Vaccine Research, World Health Organization

David Hipkiss, Chief Executive Officer, Enesi Pharma Limited

Dr Karin Hoelzer, Senior Officer, Pew Charitable Trusts

Marc Hoffman, CMO, Celerion

Dr Wayne Hogrefe, VP, Vaccines, Q² Solutions

Dr Peter Hotez, Dean, National School of Tropical Medicine, Director, Texas Children’s Hospital Center, Baylor College of Medicine

Dr John A. Howard, President, Applied Biotechnology Institute

Dr Randall Hyer, Vice President, Clinical Development and Medical Affairs, Dynavax

Dr Ken Ishii, Professor and Project Leader, Osaka U.i

Dr Hector Izurieta, Epidemiologist, Immediate Office of the Director. Office of Biostatistics and Epidemiology, CBER, U.S. Federal Drug Administration

Reggie Jackson, Senior Manager of Supply Chain Security, Pfizer

Julie Jacobson, Senior Program Officer, Neglected Tropical Diseases, The Bill & Melinda Gates Foundation

Dr Karin Jooss, Chief Scientific Officer, Gritstone Oncology

Elizabeth Joseph, Research Scientist, Baxter BioPharma Solutions

Dr Jorge Kalil, Former director of Butantan Institute, Professor and Head Clinical Immunology, School of Medicine, University Of Sao Paulo

Dr Jorge Kalil at World Vaccine Congress Washington 2018

Kemal Karaca, Director, Elanco Animal Health

Dr Cheryl Keech, Executive Medical Director, PPD

Dr Richard B Kennedy, Associate Professor of Medicine, Co-Director, Mayo Vaccine Research Group, Mayo Clinic and Foundation

Peter Khoury, CEO, Ology Bioservices

Peter Khoury at World Vaccine Congress Washington 2018

Wayne C Koff, President and CEO, The Human Vaccines Project

Camille Kotton, Clinical Director, Transplant and Immunocompromised Host Infectious Diseases, Massachusetts General Hospital

Dr Carleigh Krubiner, Research Scholar, Johns Hopkins Berman Institute of Bioethics

Dr Carleigh Krubiner at World Vaccine Congress Washington 2018

Dr Mahesh Kumar, Vice President, Global Biologics Research, Zoetis

Dr Arvind Kumar (Mahajan), Research Advisor, Elanco

Dr Peter Kwong, Chief, Structural Biology Section, NIH

Dr Rhonda LaFleur, Principal Scientist, Merck Animal Health

Dr Hans Langedijk, Director of Subunit Vaccine Design, Janssen Vaccines & Prevention B.V.

Dr Heidi Larson, Professor of Anthropology, Risk and Decision Science, London School of Hygiene and Tropical Medicine

Dr Shahram Lavasani, Founder and Chief Executive Officer, ImmuneBiotech Ab

Dr Patricia Lawman, Chief Executive Officer, Morphogenesis I.N.C.

Dr Stéphane Lemiere, Global Director of Technical Services, Boehringer Ingelheim France

Kathy Lenhard, President PanAmerican, PanAmerican Clinical Research LLC

Dr Ching Ching Leow, AVP, Immuno-Oncology Clinical Development, Eli Lilly and Company

Dr Myron M. Levine, Grollman Distinguished Professor and Director, Center for Vaccine Development, University of Maryland School of Medicine

Dr Hyam Levitsky, Executive Vice President and Chief Scientific Officer, Juno Therapeutics

Dr Fiona Lin, Small Molecule Analytical Chemistry and Quality Control, Genentech

Thomas Lingelbach, President and Chief Executive Officer, Valneva

Dr Pascal Longchamp, Chief Corporate & Commercial Officer, Scarab Genomics

Dr Ira Longini, Professor & Co-director, Center for Statistics and Quantitative Infectious Diseases (CSQUID) Emerging Pathogens Institute, University of Florida

Dr Robin Löving, CSO, Salipro Biotech AB

Dr Robin Löving at World Vaccine Congress Washington 2018

Dr Joan Lunney, Supervisory Research Scientist, USDA ARS BARC Animal Parasitic Diseases Laboratory

Dr Nicole Lurie, Strategic Advisor to CEO, CEPI

Dr David Mantus, Chief Development Officer, Arsanis Inc

Dr Natalie Mazur, Clinician-Investigator, Wilhelmina Children’s Hospital in Utrecht

Dr Mike McCluskie, Team Leader Immunomodulation, Senior Research Officer, National Research Council

Dr Douglas Mcneel, Chief Scientific Founder and Head of M.V.I. Scientific Advisory Board, Madison Vaccines Inc.

Dr Jan Joseph Melenhorst, Director of Product Development and Correlative Sciences Laboratory, University of Pennsylvania

Mark Meltz, Executive Vice President and Chief Business Development and Legal Officer, PaxVax Inc

Prof Kingston H.G. Mills, Professor of Experimental Immunology, Trinity College Dublin

Prof Emanuele Montomoli, Prof in Public Health University of Siena & CSO, VisMederi

Prof James Moon, Assistant Professor of Biomedical Informatics, University of Michigan

Dr Martin Moore, Associate Professor, Interim Director of Research, Pediatric Infectious Diseases, Emory University Children’s Center

Dr Vasee Moorthy, Coordinator, Research, Ethics, Knowledge Uptake, Department of Information, Evidence and Research, & Team Leader, R&D Blueprint, World Health Organization

Dr Alex Morrow, Chair of the International Research Consortium, STAR-IDAZ International Research Consortium on Animal Health

Dr Sally Mossman, VP, Head Discovery Performance Unit, US, GSK Vaccines

Wilhelm (Willie) Muehlhausen, VP eCOA & Innovation, ICON

Wilhelm (Willie) Muehlhausen at World Vaccine Congress Washington 2018

Dr Thomas Muster, Managing Director and Chief Scientific Officer, Vivaldi Biosciences Inc

Dr Gary Nabel, Chief Scientific Officer & Senior Vice President Head, North America R&D Hub, Sanofi Pasteur

Stephen Nagler, Executive Director, MedPro Investors LLC

Stephen Nagler at World Vaccine Congress Washington 2018

Dr Christopher Nelson, aVP, Vaccine Public Affairs, Dengue, Sanofi Pasteur

Dr John Nieland, Chief Operating Officer, 2A Pharma

Dr Nicolas Noulin, Associate Director, Scientific Operations, hVIVO

Dr Paul Offit, Chief of Infectious Diseases, & Director of the Vaccine Education Center, Childrens Hospital of Pennsylvania

Dr Derek O'Hagan, Global Head of Discovery Support and New Technology, GSK Vaccines

Dr Saad B Omer, William H. Foege Professor of Global Health Professor of Epidemiology & Pediatrics, Emory University - School of Medicine

Dr Walter A Orenstein, Professor and Associate Director, Emory Vaccine Center Emory University

Dr Justin R Ortiz, Former Medical Officer, Initiative for Vaccine Research for WHO & Associate Professor of Medicine, University of Maryland

Professor Klaus Osterrieder, Managing Director, Institute of Virology, Department of Veterinary Medicine, Freie Universitt Berlin

Dr Leandro Padilla, R & D Director, Natural Response

Dr Drew Pardoll, Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy Professor of Oncology, John Hopkins University

Dr Raphael Pareschi, Pharmacovigilance Associate Director, PV Country lead deputy,, Merck & Co

Ranjeet Patil, Segment Head, Vaccines and Viral Therapies – Bioprocessing, MilliporeSigma

Ranjeet Patil at World Vaccine Congress Washington 2018

Dr Viliam Pavliak, Head of Vaccine Development, International Vaccine Institute

Dr Franco Pissani, Vice President, Business Development & Scientific Advisor, Mabtech

Dr Lisa Plitnick, Senior Principal Scientist, Vaccines Therapeutic Area Lead, Safety Assessment and Laboratory Animal Resources, Merck Research Laboratories

Prof Stanley Plotkin, Emeritus Professor, University of Pennsylvania School Of Medicine

Dr Laurent Poirot, Head of Early Discovery, Cellectis

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Andrew Potter, CEO, VIDO-InterVac

Dr Jean-Francois Poulin, Associate Director, Caprion Biosciences

Dr Steve Projan, Senior Vice President of Innovative Medicines, Research and Development and Head of Infectious Diseases and Vaccines, MedImmune Inc

Dr Hari Pujar, Vice President Technical Development and Manufacturing, Moderna Therapeutics

Dr Fred Ramsdell, Vice President, Research, Parker Institute for Cancer Immunotherapy

Dr Kyle Rasbach, Partner, Pappas Ventures

Dr Steven Reed, President, Founder & CEO, Infectious Disease Research Institute

Dr Robert Reiner, Assistant Professor, Global Health, University Of Washington

Dr Robert Reiner at World Vaccine Congress Washington 2018

Dr Arthur Reingold, Professor and Division Head Epidemiology, Former ACIP Member, UC Berkeley School of Public Health

Felix Rey, Head of Structures, Institut Pasteur

Felix Rey at World Vaccine Congress Washington 2018

Dr Merlin Robb, Deputy Director MHRP for Clinical Research, Director, HJF Component of MHRP, U.S. Military HIV Research Program

Matt Roberge, Senior Director, Local Market Access & Support, Pfizer

Dr Scot Roberts, Chief Scientific Officer, Altimmune

Dr Scot Roberts at World Vaccine Congress Washington 2018

Dr Simona Rondini, Vaccine Development Lead, COPD Vaccine, GSK Vaccines

Jeffrey Rowland, Director, Global Operational Partnerships, Gavi, The Vaccine Alliance

Dr Dorit Rubinstein Reiss, Professor of Law, UC Hastings College of the Law

Bernard Rudnick, Managing Partner, Capgenic Advisors

Dr Clifford Sachs, Director, R&D Toxicology, MedImmune Inc

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Sushant Sahastrabuddhe, Director, Enteric Fever, International Vaccine Institute

Dr Sushant Sahastrabuddhe at World Vaccine Congress Washington 2018

Dr Daniel Salmon, Prof Global Disease Epidemiology and Control; Deputy Director JHU’s Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health

Surya Sankuratri, Executive Director, Merck

Surya Sankuratri at World Vaccine Congress Washington 2018

Dr Mathuram Santosham, Professor, Johns Hopkins University

Dr Mathuram Santosham at World Vaccine Congress Washington 2018

Dr Niranjan Sardesai, COO, Inovio Pharmaceuticals

Dr Beate Schmoele-Thoma, Senior Director Vaccine Clinical Research and Development, Clinical Lead, RSV, Pfizer

Michael A. Schrader, Co-Founder and Chief Executive Officer, Vaxess Technologies, Inc

Dr Jason Schwartz, Assistant Professor of Health Policy, Yale School of Public Health

Dr Robert Seder, Chief of the Cellular Immunology Section, NIAID, NIH

Dr Aiman Shalabi, Chief Medical Officer, Cancer Research Institute

Dr Angela Shen, CAPT, US Public Health Service, Senior Science Policy Advisor, National Vaccine Program Office, U.S. Department of Health & Human Services

Pei-Yong Shi, Kempner Professor of Human Genetics, University of Texas Medical Branch

Dr Li Shi, Chief Executive Officer, Shanghai Zerun Biotechnology Co Ltd

Dr Vivek Shinde, Director, Clinical Development Lead, Older Adult Influenza and RSV Vaccines, Novavax

Dr Sushma Shivaswamy, Vice President, Research and Development, XBiotech

Dr George Siber, CSO of ClearPath Vaccines & Scientific Advisory Board of Genocea, ClearPath Vaccines

Dr George Siber at World Vaccine Congress Washington 2018

Nigel Silman, Senior Business Development Manager, Public Health England

Nigel Silman at World Vaccine Congress Washington 2018

Dr Raphael Simon, Assistant Professor of Medicine, University of Maryland School of Medicine

Dr Rahul Singhvi, Chief Operating Officer, Takeda Vaccines

Tanima Sinha, Project Officer and Team lead, U.S. Department of Health & Human Services

B.T. Slingsby, Chief Executive Officer and Executive Director, Global Health Innovative Technology Fund

Dr Igor Smolenov, Head of Clinical Development, Infectious Diseases, Moderna Therapeutics

Stacy Sneeringer, Senior Research Economist, Economic Research Service United States Department of Agriculture USDA

Dr Max Søgaard, Director process dev, ExpreS2ion Biotechnologies

Bruno Speder, Head of Clinical Regulatory Affairs, SGS – Life Science Services

Dr Erin Spiegel, Director of Scientific Affairs, PharmaJet

Dr Uwe Staerz, CSO, Greffex Inc

Dr Jens-Ulrich Stegmann, Vice President Head Clinical Safety and Pharmacovigilance, G.S.K Biologicals

Mr Robert Steinglass, Director, Immunization Center, John Snow Inc

Dr Koert Stittelaar, Director Preclinical Services, Viroclinics Biosciences

Dr Jeffrey Stoddard, US Medical Affairs Lead for Zoster Vaccine, GSK Vaccines

Dr Jeffrey Stoddard at World Vaccine Congress Washington 2018

Dr Walter Straus, Associate Vice President, Therapeutic Area Head, Clinical Safety and Risk Management, Merck Research Laboratories

Dr Darrel Styles, Senior Staff Veterinarian, U.S.D.A. A.P.H.I.S. Veterinary Services

Dr David Subich, Medical Director/Physician Investigator, Bioclinica Research Network

Dr Kena Swanson, Senior Principal Scientist, Viral Vaccines, Research Lead, RSV, Pfizer

Ousmane Tamba Dia, Senior Immunization Specialist, Unicef

Dr Erich Tauber, Chief Executive Officer and Founder, Themis Bioscience

Dr Seth Thomas, Head of Process Development, The Duke Human Vaccine Institute

Dr William Thomas, Chief Technical Officer, Paragon Bioservices

Dr Marta Tomasi, Post-doc researcher, Free University of Bozen Bolzano

Steven Townson, Oncology Scientific Director, Principal Scientist, Clinical Research Oncology Early Development, Merck Research Laboratories

Dr Vu Truong, Founder, Chief Executive Officer and Director, Aridis Pharmaceuticals

Dr Sean Tucker, CSO and VP Research, Vaxart

Dr Jeffrey Ulmer, Head, Preclinical R&D US, GSK Vaccines

Dr Michael Vajdy, CSO, Epito Genesis Inc

Dr David Vaughn, Senior Vaccine Development Leader for Influenza and Dengue Vaccines, GSK Vaccines

Thomas Verstraeten, Managing director, P-95

Dr Matthias Von Herrath, Professor in Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology

Dr Thomas W Scott, Distinguished Professor, University of California Davis

Dr Brian Ward, Medical Officer, Medicago

Jim Wassil, Vice President, Business Unit Lead, Vaccines, Global Health and Value, Pfizer

Laurie Werner, Director, PATH

Dr Stephen Whitehead, Senior Associate Scientist, NIAID, NIH

Dr Stephen Whitehead at World Vaccine Congress Washington 2018

Dr Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services

Edward Wilson, Director, Center for Health Logistics, John Snow Inc

Dr Ashley Wivel, Executive Director, Global Clinical Safety and Risk Management, Global Safety Physician for Ebola Vaccine Program, Merck Research Laboratories

Dr Yan-ping Yang, Senior Director, Head of Bioprocess R&D North America, Sanofi Pasteur

Dr Masahide Yano, Research Scientist, U.S. Food and Drug Administration

Shahrzad Yavari, Program Director, Nexleaf Analytics

Dr Katherine Yih, Assistant Professor, Department of Population Medicine, Havard Medical School and, Harvard Pilgrim HealthCare Institute

Alan Young, CSO, Medgene Labs

Darin Zehrung, Portfolio Leader of Vaccine and Pharmaceutical Delivery Technologies and Senior Technical Officer, Path

Dr Xiaosong (Susan) Zhang, Assistant Medical Director, Genentech

Dr Xiaoping Zhu, Interim Associate Dean & Department Chair, University of Maryland, Baltimore

Dr Robert Zolynas, Vice President, Bayer Animal Health

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071